Adult-Use
An entrepreneur’s guide to the recreational cannabis market in Europe
Michael Sassano, CEO of Somai Pharmaceuticals reflects on Q3 2022.
admin
21stories
7 Declast updated
More in admin
- CBD Market
Chaos in cannabis: is the Novel Foods process fit for purpose?
Chris Tasker of Global Cannabinoid Solutions explores cognitive bias, synthetic compounds, the endocannbinoid system and animal testing in cannabis.
- Cultivation
Red light receptor activation: a cause of unwanted hermaphroditism?
In the final article of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses red light and near-infrared photoreceptors in cannabis cultivation.
- Cultivation
Cannabis cultivation: the artificial lighting minefield
In the second article of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the use of artificial lighting for cannabis cultivation.
- Cultivation
Cannabis cultivation: the additional lighting paradox
In the first of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the use of lighting for improving cannabis yield.
- Opinion
Brains Bioceutical: building a cannabis dream team
CEO of Brains Bio, Rick Brar, discusses his philosophy that a CEO is only as good as the team they lead.
- Cultivation
Exploring cannabis yield optimisation with PharmaSeeds
In this article, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the essential elements central to producing a successful crop.
- Cultivation
Germplasm selection – from seed culture to tissue culture
In this article, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the pros and cons of types of germplasm selection.
- CBD Market
Quanna: breaking taboos, creating a brand and building a community
Dr Dmitry Loktionov discusses the UK’s first CBD-based sexual wellness company, Quanna.
